Malin Life Sciences Holdings Ltd Poseida Therapeutics, Inc. (PSTX) insider trading activity
Malin Life Sciences Holdings LTD is > 10% Shareholder of Poseida Therapeutics, Inc.. Currently has a direct ownership of 11.8 Million shares of PSTX, which is worth approximately $32.1 Million. The most recent transaction as insider was on Aug 08, 2022, when has been sold 2,150,000 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $7,525,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
11.8M
0%
3M change
0%
12M change
Total Value Held
$32.1 Million
Malin Life Sciences Holdings Ltd Transaction History
MLS
Malin Life Sciences Holdings LTD
> 10% Shareholder
Dublin, Ireland, L2